Illumina Sole Source Reagents and Preventative Maintence FY27

The State of Illinois Department of Public Health, Office of Disease Control, Division of Laboratories has awarded a sole source contract to Illumina, Inc. valued at $644,202.11 for the period July 1, 2026 through June 30, 2027. The contract provides whole genome sequencing (WGS) reagents, instrument maintenance services, and software solutions for sequencing equipment deployed across four IDPH laboratory locations: Springfield, Chicago, Carbondale, and Central facilities. The procurement includes annual support plans for five sequencing instruments: one iSeq 100 unit, two NextSeq 2000 units, and two MiSeq DX units, with individual support plan costs ranging from $3,585.56 to $49,121.08 per instrument. Additionally, the contract encompasses a BaseSpace Sequence Hub Enterprise subscription and up to $500,000 in sequencing reagents, consumables, library preparation kits, enrichment panels, and related supplies to support an estimated 4,000 to 6,000 samples annually.

Illumina, Inc. was selected as the sole source vendor due to its exclusive manufacturer status and role as the only authorized provider of certified maintenance services and proprietary reagents for the specified sequencing instruments. The contract is funded through federal sources and does not include renewal options. The procurement supports critical public health functions including epidemiological disease investigations, newborn screening for genetic disorders, pathogen typing, and food and waterborne outbreak tracking, as well as participation in the Centers for Disease Control and Prevention PulseNet disease surveillance program. IDPH-DOL negotiated a five percent discount contingent upon the one-year contract commitment.